Publisher: Medscape


Drug-Resistant Shigella Surges in Adult Men

In the Media Icon

Cases of extensively drug-resistant (XDR) Shigella, for which no approved treatment is available, increased significantly between 2011 and 2023, based on data from approximately 17,000 isolates.


The Ethics of Referring Patients to the Hospital Pharmacy

In the Media Icon

As an increasing number of physicians leave private practice to work for hospitals or private equity firms, the risk of conflicts of interest increases.


RSV Springs Ahead

In the Media Icon

“A ripple effect from the COVID pandemic may be one reason for the shift in RSV circulation this year, as natural immunity to RSV may have been reduced with mitigation measures that were in place at the time,” said Shirin Mazumder, MD, infectious diseases specialist and associate professor at the University of Tennessee Health Science… Read More


You Had a Seizure, No I Didn’t: The Accuracy of Patient Seizure Diaries

In the Media Icon

Andrew Wilner is a professor of neurology at the University of Tennessee Health Science Center, Memphis, and a seasoned neurologist and epilepsy expert who has mastered the less conventional locum career path.


Exercise Training Benefits Patients With HIV Below the Surface

In the Media Icon

A 16-week exercise training program showed broad benefits, including cellular damage repair and slowdown in epigenetic aging, in people with HIV (PWH), based on new data presented at the Conference on Retroviruses and Opportunistic Infections (CROI) 2026 Annual Meeting.


HIV Hits the Nervous System Early

In the Media Icon

Cerebrospinal fluid (CSF) samples from individuals with early HIV infection already showed signs of inflammation compared to samples from individuals without HIV, based on new data presented at the Conference on Retroviruses and Opportunistic Infections (CROI) 2026 Annual Meeting.


Cerebrospinal Fluid Biomarkers Suggest Impact of Herpes on Brain Health

In the Media Icon

Underlying herpes infection may have an impact on brain health in people with HIV (PWH), according to new data presented at the Conference on Retroviruses and Opportunistic Infections (CROI) 2026 Annual Meeting.


Pritelivir Shows Promise for HSV

In the Media Icon

Pritelivir, a new oral therapy, was significantly more effective against herpes simplex virus (HSV) than a comparator treatment for immunocompromised patients with refractory infections, based on data from 101 individuals.